3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
25
Ovarian Neoplasms
19
Neoplasms
12
Fallopian Tube Neoplasms
12
Carcinoma, Hepatocellular
11
Endometrial Neoplasms
7
Neoplasm Metastasis
6
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Glioblastoma
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Lung Neoplasms
3
Liver Neoplasms
3
Digestive System Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Mouth Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Intestinal Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Brenner Tumor
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Astrocytoma
2
Interventions
Cyclophosphamide
5
fludarabine phosphate
3
Vincristine
3
Methotrexate
3
Etoposide
3
pegaspargase
2
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Leucovorin
2
Doxorubicin
2
Dexamethasone
2
Cytarabine
2
Calcium Dobesilate
2
venetoclax
1
prednylidene
1
hydrocortisone hemisuccinate
1
fludarabine
1
exifone
1
deltacortene
1
calaspargase pegol
1
azathiopurine
1
aldesleukin
1
Thioguanine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Bevacizumab
×
30 days
×
Clear all
No trials found.